Milvexian shows promise as a new oral anticoagulant, but observers say more data are needed to confirm a bleeding advantage with this emerging class of drugs. Medscape Medical News…
Read more
Cycling to a second JAK inhibitor and switching to a biologic disease-modifying antirheumatic drug were equally effective at ameliorating rheumatoid arthritis symptoms. Medscape Medical News…
Read moreMedPage Today) — A significantly higher proportion of patients with moderate to severe ulcerative colitis who responded well to upadacitinib (Rinvoq) induction achieved clinical remission with maintenance therapy compared to those who switched…
Read more